Autolus Therapeutics (AUTL) Gets a Buy Rating from HC Wainwright In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Autolus Therapeutics (AUTL), with a price target of $13.00. The company’s shares closed last Wednesday at $8.97. According to TipRanks.com, Burns is a 5-star analyst with an average return of […]
Read More
Sanofi-backed Abcuro bags $42M to trial KLRG1 immunotherapy Abcuro has raised $42 million in a Sanofi Ventures co-led series A to advance anti-KLRG1 treatments for autoimmune diseases and cancers. The financing positions a leadership team featuring David de Graaf, Ph.D., and John Edwards to run a proof-of-mechanism clinical trial in sporadic inclusion body myositis (IBM) […]
Read More
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). Global Hemoglobinopathies Market: Description The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to […]
Read More
This post discusses Reliability of Marketing Research Finding and market research finding is the conclusion we get with the help of survey and other marketing research program. In order to assess validity and reliability, it is required to understand its usage and terms in the different market segment. Market research finding is the conclusion we […]
Read More
Dr. Edward Libby Describes Multiple Myeloma Symptoms Dr. Edward Libby, describes multiple myeloma symptoms. The most common symptoms are: pain, most often in the back because the bones have gotten thin, kidney failure which there aren’t usually any symptoms, anemia/low blood counts which can cause extreme fatigue. It’s common for patients to go to their […]
Read More
Why prognostic tests are now mandated for breast cancer by International bodies? Representative image by Dr Vineeth Govinda GuptaConsultant Medical Oncologist, Artemis Hospitals, Gurugram Over the last 30 years, breast cancer treatment has been steadily moving away from a one-size fits all approach. This is in account of the hard work of various researchers and […]
Read More
Liver cancer cells cause stromal cells to secrete protein that enhances tumor growth Hepatocellular carcinoma (HCC), frequently seen in patients with liver cirrhosis caused by alcohol abuse or chronic viral hepatitis, is the most common form of liver cancer worldwide. As such, it is the third-most common cause of cancer-related death and has a notoriously […]
Read More
The FDA needs to apply its Covid-19 flexibility to pediatric cancer One of the few bright spots in the Covid-19 pandemic has been the swift development of therapies and vaccines that — beyond all odds — made it to patients in mere months versus years. The government, specifically the Food and Drug Administration, has played […]
Read More
Multiple Myeloma Drugs Market Global Industry Analysis 2020 – 2026 | Coherent Market insights … Most Recent Report On The Global “Multiple Myeloma Drugs Market” The Multiple Myeloma Drugs Market report is an investigative study of the market, along with an analysis of its key segments. The report is constructed through primary and secondary research. The […]
Read More
Syncona upbeat on developments at Autolus Life science investor Syncona updated the market on its portfolio company Autolus on Wednesday, announcing that it would prioritise the development of the ‘AUTO1’ programme for adult acute lymphoblastic leukemia (ALL), based on the positive data generated in its phase 1 and 2 studies to date and a high […]
Read More